AbbVie said Class II director Jennifer L. Davis notified the board on October 28, 2026 of her intent to resign, effective November 2, 2026, after her appointment as chief executive officer of Align Technology. The company stated the resignation is not the result of any dispute or disagreement with AbbVie on operations, policies or practices. No replacement director or change in board size was disclosed.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
